Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study

Abstract Introduction Subjects with intellectual disability are usually excluded from clinical trials and there is limited evidence-based guidance for the choice of antiseizure medications in this vulnerable population. The study explored the effectiveness of brivaracetam (BRV) in people with epilep...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, Sara Casciato, Emanuele Cerulli Irelli, Valentina Chiesa, Filippo Dainese, Giovanni De Maria, Giuseppe Didato, Giancarlo Di Gennaro, Giovanni Falcicchio, Martina Fanella, Edoardo Ferlazzo, Massimo Gangitano, Angela La Neve, Oriano Mecarelli, Elisa Montalenti, Alessandra Morano, Federico Piazza, Chiara Pizzanelli, Patrizia Pulitano, Federica Ranzato, Eleonora Rosati, Laura Tassi, Carlo Di Bonaventura, on behalf of BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) Group Membership
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Adis, Springer Healthcare 2025-03-01
Serie:	Neurology and Therapy
Soggetti:	Antiseizure medication Brivaracetam Focal seizures Epilepsy Intellectual disability
Accesso online:	https://doi.org/10.1007/s40120-025-00717-x
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!